Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-30

Clinical Trial Update: Laryngomalacia Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating laryngomalacia has been withdrawn. The sponsor is the Children's & Women's Health Centre of British Columbia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's & Women's Health Centre of British Columbia | Conditions: Laryngomalacia | Phase 1 | Status: WITHDRAWN